AR059462A1 - Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de utilizacion de los mismos - Google Patents

Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de utilizacion de los mismos

Info

Publication number
AR059462A1
AR059462A1 ARP060101766A ARP060101766A AR059462A1 AR 059462 A1 AR059462 A1 AR 059462A1 AR P060101766 A ARP060101766 A AR P060101766A AR P060101766 A ARP060101766 A AR P060101766A AR 059462 A1 AR059462 A1 AR 059462A1
Authority
AR
Argentina
Prior art keywords
peptides derived
methods
pharmaceutical compositions
clear
caseina
Prior art date
Application number
ARP060101766A
Other languages
English (en)
Spanish (es)
Inventor
Jose Mario Iscovich
Nissim Silankovich
Javier Iscovich
Original Assignee
Mileutis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mileutis Ltd filed Critical Mileutis Ltd
Publication of AR059462A1 publication Critical patent/AR059462A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ARP060101766A 2005-05-02 2006-05-15 Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de utilizacion de los mismos AR059462A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67629205P 2005-05-02 2005-05-02
US68869705P 2005-06-09 2005-06-09

Publications (1)

Publication Number Publication Date
AR059462A1 true AR059462A1 (es) 2008-04-09

Family

ID=37308387

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060101766A AR059462A1 (es) 2005-05-02 2006-05-15 Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de utilizacion de los mismos

Country Status (18)

Country Link
US (2) US7968513B2 (enExample)
EP (1) EP1890720B1 (enExample)
JP (1) JP5247429B2 (enExample)
KR (2) KR20130122979A (enExample)
CN (1) CN106421749A (enExample)
AR (1) AR059462A1 (enExample)
AU (1) AU2006242842B2 (enExample)
BR (1) BRPI0611301A2 (enExample)
CA (1) CA2607155C (enExample)
CL (1) CL2011000039A1 (enExample)
EA (1) EA016039B1 (enExample)
ES (1) ES2400511T3 (enExample)
IN (1) IN2014DN10391A (enExample)
MX (1) MX2007013866A (enExample)
NZ (1) NZ563936A (enExample)
PL (1) PL1890720T3 (enExample)
UY (1) UY29515A1 (enExample)
WO (1) WO2006117784A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2400511T3 (es) * 2005-05-02 2013-04-10 Mileutis Ltd. Composiciones farmacéuticas que comprenden péptidos derivados de la caseina y métodos para el uso de las mismas
JP5507555B2 (ja) * 2008-06-30 2014-05-28 チョ−エー・ファーム・カンパニー・リミテッド 豚のαＳ１カゼイン遺伝子、そのプロモーター、及びその用途
US8133916B1 (en) 2009-03-10 2012-03-13 Amelgo, LLC Control of milk production and mammary involution
US20110017323A1 (en) * 2009-07-22 2011-01-27 Ewa Herbst Method and apparatus for inline testing
CA2797658C (en) * 2010-04-21 2021-06-08 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections
FR2971423B1 (fr) * 2011-02-15 2014-01-10 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
ES2759980T3 (es) 2012-03-19 2020-05-12 Mileutis Ltd Péptidos para el manejo de la lactación
EP2810695A1 (en) * 2013-06-06 2014-12-10 Ceva Sante Animale Compositions and Method for controlling infections in non-human mammals using acute phase proteins
AU2017358060B2 (en) * 2016-11-09 2023-05-04 Charles Sturt University Livestock supplement and use thereof
CN110267550B (zh) * 2016-12-13 2022-08-30 帝斯曼知识产权资产管理有限公司 多不饱和脂肪酸盐制剂(i)
CN108017709B (zh) * 2017-12-12 2020-04-10 浙江辉肽生命健康科技有限公司 一种生物活性多肽kepmigvnqela及其制备方法和应用
MX2022010250A (es) * 2020-02-19 2022-11-09 Perfect Day Inc Proteínas recombinantes hipoalergénicas de leche y composiciones que comprenden las mismas.
EP4619011A1 (en) * 2022-11-17 2025-09-24 Mileutis Ltd. Compositions and methods for modulating mammary disorders and conditions
AU2024274533A1 (en) * 2023-05-16 2025-12-04 Mileutis Ltd. Enhanced milk quality

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764670A (en) * 1970-10-28 1973-10-09 Ministry Of Agriculture Polypeptidic anti-biotic substances derived from casein
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
US5405756A (en) * 1982-03-30 1995-04-11 Meiji Seika Kaisha, Ltd. Transparent acid drink containing acid-soluble casein phosphopeptide
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
ES2149771T3 (es) * 1991-04-19 2000-11-16 Univ Melbourne Produccion de fosfopeptidos a partir de la caseina.
US5227154A (en) * 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus
KR0140248B1 (ko) * 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
AUPO566297A0 (en) * 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
AUPP494798A0 (en) * 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
AU775999B2 (en) 1999-08-24 2004-08-19 Meiji Seika Pharma Co., Ltd. Growth promoting compositions for mammals and method of promoting the growth of mammals by using the same
US6391849B1 (en) * 1999-11-19 2002-05-21 Agricultural Research Organization, The Volcani Center Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis
US7666996B2 (en) * 2000-03-01 2010-02-23 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
CN1496368A (zh) * 2001-03-09 2004-05-12 明治制果株式会社 免疫增强剂
BRPI0507822A (pt) 2004-03-01 2007-07-10 Peptera Pharmaceuticals Ltd método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição autoimune ou infecciosa, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição do sangue, método e composição farmacêutica para modular a formação de células do sangue, método e composição farmacêutica para intensificar a mobilização periférico da célula tronco, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição metabólica, método e composição farmacêutica para a prevenção ou o tratamento das condições associadas com doses mieloablativas de quimioradioterapia suportadas pelo transplante autólogo de medula óssea ou de células tronco do sangue periférico (asct) ou pelo transplante alogenéico de medula óssea (bmt), método e composição farmacêutica para aumentar o efeito de um fator estimulante de células do sangue, método e composição farmacêutica para intensificar a colonização de células tronco do sangue doadas em um receptor mieloablatado, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição bacteriana, composição farmacêutica para o tratamento ou a prevenção de uma indicação selecionada do grupo que consiste em doença ou condição autoimune, doença viral, infecção viral, doença hematológica, deficiências hematológicas, trombocitopenia, pancitopenia, granulopenia, hiperlipidemia, hipercolesterolemia, glucosuria, hiperglicemia, diabetes, aids, hiv-1, distúrbios de células t auxiliares, deficiências de células dendrìticas, deficiências de macrofagos, distúrbios de células tronco hematopoiéticas incluindo distúrbios com plaquetas, linfócitos, células do plasma e neutrófilos, condições pré-leucêmicas, condições leucêmicas, distúrbios do sistema imunológico resultantes da terapia de quimioterapia ou de radiação, distúrbios do sistema imunológico humano resultantes do tratamento das doenças de deficiência imunológica e infecções bacterianas, composição farmacêutica para o tratamento ou a prevenção de um indicação selecionada do grupo que consiste em doença hematológica, deficiências hematológicas, trombocitopenia, pancitopenia, granulopenia, deficiências de células dendrìticas, deficiências de macrofagos, distúrbios de células tronco hematopoiéticas incluindo distúrbios com plaquetas, linfócitos, células do plasma e neutrófilos, condições pré-leucêmicas, condições leucêmicas, sìndrome mielodisplástiacas, malignidades não mielóides, anemia plástica e insuficiência da medula óssea, peptìdeo purificado, peptìdeo quimérico purificado, peptìdeo quimérico, composição farmacêutica, composição farmacêutica para a prevenção ou o tratamento de uma condição associada com um agente infeccioso de sars, método de processamento a baixa temperatura de hidrolisato proteolìtico de caseìna e hidrolisato de proteìna de caseìna
ES2400511T3 (es) * 2005-05-02 2013-04-10 Mileutis Ltd. Composiciones farmacéuticas que comprenden péptidos derivados de la caseina y métodos para el uso de las mismas

Also Published As

Publication number Publication date
CL2011000039A1 (es) 2011-06-10
KR101340676B1 (ko) 2013-12-18
EP1890720B1 (en) 2013-01-09
AU2006242842B2 (en) 2011-12-08
KR20080012933A (ko) 2008-02-12
CA2607155C (en) 2016-09-13
PL1890720T3 (pl) 2013-06-28
US20110212886A1 (en) 2011-09-01
WO2006117784A2 (en) 2006-11-09
NZ563936A (en) 2010-03-26
JP5247429B2 (ja) 2013-07-24
IN2014DN10391A (enExample) 2015-08-14
EP1890720A2 (en) 2008-02-27
AU2006242842A1 (en) 2006-11-09
EP1890720A4 (en) 2010-05-26
ES2400511T3 (es) 2013-04-10
KR20130122979A (ko) 2013-11-11
US7968513B2 (en) 2011-06-28
US8338363B2 (en) 2012-12-25
CA2607155A1 (en) 2006-11-09
MX2007013866A (es) 2008-04-07
EA016039B1 (ru) 2012-01-30
WO2006117784A3 (en) 2009-05-22
JP2008540399A (ja) 2008-11-20
EA200702401A1 (ru) 2008-08-29
US20090069218A1 (en) 2009-03-12
BRPI0611301A2 (pt) 2010-08-31
CN106421749A (zh) 2017-02-22
UY29515A1 (es) 2007-11-30

Similar Documents

Publication Publication Date Title
AR059462A1 (es) Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de utilizacion de los mismos
US10264766B2 (en) Antimicrobial compounds and compositions, and uses thereof
US10106567B2 (en) Biofilm inhibiting compositions enhancing weight gain in livestock
DOP2019000250A (es) Composicion farmaceutica que comprende selexipag
BR112018068719A2 (pt) métodos para produzir uma resposta imunogênica em um animal aquático e composição farmacêutica
US11311511B2 (en) Biofilm inhibiting compositions enhancing weight gain in livestock
BR112015028692A8 (pt) agente preventivo ou terapêutico para mastite de animal ruminante
PE20130589A1 (es) Composiciones y metodos para suministro al sistema nervioso central de arilsulfatasa a
BR112013026032A2 (pt) composições nutricionais incluindo ácidos graxos de cadeia ramificada para cicatrização de ferida
MX2018014631A (es) Formulacion de neurotoxina.
CO6430439A2 (es) Agonistas del receptor de esfingosina -1- fosfato
WO2016060921A1 (en) Formulations for histatin protectives and therapeutics
PH12020500342A1 (en) New disinfectant for hatcheries
MX2019002386A (es) Uso de oligosacaridos de leche humana en el engorde de terneros.
CN102389030A (zh) 枯草杆菌糖肽素168的用途
RU2009100745A (ru) Способ лечения слюннокаменной болезни
US20200296998A1 (en) Feed compositions enhancing zootechnical performance in livestock
Delpech et al. New bacteriocin of E. Faecalis CECT7121: synergy studies against multidrug-resistant enterococci isolated from bovine mastitis
RU2008124738A (ru) Кормовая добавка
ES2246691B1 (es) Composicion de acido l(+)-lactico de origen natural y organico.
Vostretsov et al. EXPERIENCE OF USE OF HYGIENIC PRODUCTS BASED ON CHLORHEXIDINE DIGLUCONATE FOR PREVENTION OF TEATS DISEASES OF LACTATING COWS
Khangal et al. Therapeutic evaluation of different antimicrobial agents along with antioxidants in the treatment of caprine mastitis.
RU2015112538A (ru) Способ лечения мастита у коров
TH118888A (th) วัคซีนต่อต้านเห็บโค
RU2014144423A (ru) Способ повышения репродуктивных функций пушных зверей и жизнеспособности их приплода

Legal Events

Date Code Title Description
FC Refusal